BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
Clinical trial NCT04454528 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04454528
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2026-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.